A Not-in-the-Textbooks Discovery for Glioblastoma, Jay Hartenbach & Dr. Will Decker, Diakonos Oncology
About this episode
Dr. Moira Gunn discusses Diakonos Oncology's innovative approach to glioblastoma treatment with Dr. Will Decker and Jay Hartenbach.
On this episode of BioTech Nation, Dr. Will Decker and Jay Hartenbach join Moira to talk about Diakonos Oncology's unique approach to cancer immunotherapy, and how a discovery made over two decades ago started it all. Now, with a new drug entering Phase II human trials for Glioblastoma treatment, that discovery could mean a pathway to treating aggressive cancers...
More episodes of BioTech Nation ... with Dr. Moira Gunn
- Two Drug Approvals in Two Years...Michael Metzger, CEO, Syndax Pharmaceuticals
- Fighting Hard-to-Treat Cancers...Dan Schmitt, President & CEO, Actuate Therapeutics
- A Different Way to Treat Parkinson's...Dr. Jonas Hannestad & Dr. Joanne Taylor, Gain Therapeutics
- Looking Back: A 2007 Interview with Dr. J. Craig Venter
Explore listener stats, chart rankings, contacts and more on the BioTech Nation ... with Dr. Moira Gunn podcast page.